- Home
- FGEN vs NOM Comparison
FGEN vs NOM Comparison
Compare FGEN & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- NOM
- Stock Information
- Founded
- FGEN 1993
- NOM 1993
- Country
- FGEN United States
- NOM United States
- Employees
- FGEN N/A
- NOM N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- NOM Investment Managers
- Sector
- FGEN Health Care
- NOM Finance
- Exchange
- FGEN Nasdaq
- NOM Nasdaq
- Market Cap
- FGEN 34.5M
- NOM 28.0M
- IPO Year
- FGEN 2014
- NOM N/A
- Fundamental
- Price
- FGEN $0.57
- NOM $11.28
- Analyst Decision
- FGEN
- NOM
- Analyst Count
- FGEN 0
- NOM 0
- Target Price
- FGEN N/A
- NOM N/A
- AVG Volume (30 Days)
- FGEN 1.7M
- NOM 6.9K
- Earning Date
- FGEN 02-24-2025
- NOM 01-01-0001
- Dividend Yield
- FGEN N/A
- NOM 3.39%
- EPS Growth
- FGEN N/A
- NOM N/A
- EPS
- FGEN N/A
- NOM N/A
- Revenue
- FGEN $180,015,000.00
- NOM N/A
- Revenue This Year
- FGEN $22.05
- NOM N/A
- Revenue Next Year
- FGEN N/A
- NOM N/A
- P/E Ratio
- FGEN N/A
- NOM N/A
- Revenue Growth
- FGEN 16.15
- NOM N/A
- 52 Week Low
- FGEN $0.18
- NOM $8.52
- 52 Week High
- FGEN $2.93
- NOM $10.48
- Technical
- Relative Strength Index (RSI)
- FGEN 57.36
- NOM 47.25
- Support Level
- FGEN $0.51
- NOM $11.14
- Resistance Level
- FGEN $0.76
- NOM $11.53
- Average True Range (ATR)
- FGEN 0.09
- NOM 0.28
- MACD
- FGEN -0.00
- NOM -0.09
- Stochastic Oscillator
- FGEN 33.26
- NOM 14.55
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in United States. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Missouri state income taxes; its secondary investment objective is the enhancement of portfolio value. The fund invests in municipal securities as well as floating rate securities as well as derivatives such as futures, options and swap contracts to the necessary extent. Nuveen Fund Advisors, LLC acts as an investment adviser of the company.